FDA Adverse Event Death Summary report: N

THERASPHERE

MDR report key: 2431761 · Received January 26, 2012

Report

Report Number
8022247-2012-00002
Event Type
Death
Date Received
January 26, 2012
Date of Event
October 29, 2011
Report Date
January 25, 2012
Manufacturer
NORDION (CANADA) INC.
Product Code
NAW
PMA / PMN Number
H980006
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

THE PATIENT RECEIVED THERASPHERE ADMINISTRATION ON (B)(6) 2011, AND SUBSEQUENTLY COMPLAINED OF SEVERE FATIGUE AND FLUID RETENTION. HIS SERUM BILIRUBIN CONTINUED TO RISE AND HE WAS ADMITTED ON (B)(6) 2011 FOR SEVERE FATIGUE, LIVER FAILURE AND KIDNEY INJURY. THE PATIENT PASSED AWAY ON (B)(6) 2011 DUE TO LIVER FAILURE. THE TREATING PHYSICIAN HAS STATED THAT HE BELIEVES THE TIME COURSE (ALMOST IMMEDIATE ONSET OF LIVER DETERIORATION) IS ATYPICAL FOR RILD (RADIATION INDUCED LIVER DISEASE), ESPECIALLY GIVEN THAT THEY DID NOT TREAT THE RIGHT LOBE WHICH WAS THE MAJORITY OF HIS LIVER. HE ALSO DEVELOPED PORTAL VEIN OCCLUSION WHICH THE PHYSICIAN BELIEVES PROBABLY CONTRIBUTED SIGNIFICANTLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 THERASPHERE YTTRIUM-90 MICROSPHERES NAW NORDION (CANADA) INC.

Patients

Seq Age Sex Outcome Treatment
1 50 YR Death| H